Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Esophageal Carcinoma

NCT01034683 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Carcinoma

Interventions

DRUG: lobaplatin , 5-FU ,leucovorin

Sponsor

Taian Cancer Hospital